Adam Mendelsohn
Co-Founder, CEO & DirectorDr. Adam Mendelsohn, Ph.D., serves as Chief Executive Officer and Director at Vivani Medical, Inc. since August 2022 and is its Co-Founder. Dr. Mendelsohn is Chairman of the Board at Cortigent, Inc. and its Director since November 2022. He Co-Founded Second Sight Medical Products, Inc and served as Chairman and Chief Executive Officer. Dr. Mendelsohn founded Nano Precision Medical and served as its CEO from 2009 until its acquisition by Second Sight in August 2022. Dr. Mendelsohn received his Ph.D. in bioengineering at the UC San Francisco/UC Berkeley Joint Graduate Group in Bioengineering, was awarded an NSF fellowship to perform research at Kyoto University and has published multiple peer-reviewed articles describing new treatment options for Type 1 diabetes. Dr. Mendelsohn has served as a Technical Advisor to the Alfred E. Mann Institute for Biomedical Engineering at USC, a fellow of the Startup Leadership Program and is a board member of the Maestro Foundation. Dr. Mendelsohn also served as the director for the Venture Innovation Program in Life Sciences and completed his certificate in Management of Technology with the Haas School of Business.
Positions
- Company NameVivani Medical, Inc.Stock CodeVANIPositionCo-Founder, CEO & DirectorColleagues
- GGGregg G. WilliamsIndependent Chairman of the Board
- AEAnthony Edward BaldorChief Financial Officer
- TLTruc LeChief Operations Officer
- LELisa E. PorterChief Medical Officer
- DDDonald DwyerChief Business Officer & Corporate Secretary
- DMDaniel Mark BradburyIndependent Director
- AJAugust J. MorettiIndependent Director
- AMAaron MendelsohnDirector
